Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus
Clinical trial NCT03414892 · COMPLETED
Trial details
- NCT number
- NCT03414892
- Sponsor
- Yabao Pharmaceutical Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2019-01-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.